Lantheus Holdings (LNTH) EBT Margin (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly EBT Margin came in at 41.45% in Q1 2026, up 1555.0% year-on-year from 2.5% in Q1 2025, and up 119.44% on a QoQ basis from 18.89% in Q4 2025.
Lantheus Holdings (LNTH) EBT Margin (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of EBT Margin data on file, last reported at 41.45% in Q1 2026.
- On a quarterly basis, EBT Margin rose 1555.0% year-over-year to 41.45% in Q1 2026; TTM through Mar 2026 was 24.59%, a 2938.0% increase from a year earlier, with the FY2025 full-year figure at 20.77%, up 2070.0% from the prior year.
- EBT Margin for Q1 2026 stood at 41.45%, up from 18.89% in the prior quarter.
- Over the last five years, EBT Margin for LNTH reached as high as 922.69% in Q4 2023 and fell as low as 110.12% in Q4 2024.
- Historically, EBT Margin has averaged 68.21% across 5 years, with a median of 27.72% in 2022.
- Across the five-year window, EBT Margin soared 98966 bps in 2023 and plunged 103280 bps in 2024, its largest moves.
- Year by year, EBT Margin stood at 66.97% in 2022, then soared by 1478 bps to 922.69% in 2023, then plunged by 112 bps to 110.12% in 2024, then soared by 117 bps to 18.89% in 2025, then surged by 119 bps to 41.45% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 41.45% in Q1 2026, 18.89% in Q4 2025, and 11.04% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 41.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.45% |
| Dec 31, 2025 | 18.89% |
| Sep 30, 2025 | 11.04% |
| Jun 30, 2025 | 27.65% |
| Mar 31, 2025 | 25.90% |
| Dec 31, 2024 | -110.12% |
| Sep 30, 2024 | 46.50% |
| Jun 30, 2024 | 21.41% |
| Mar 31, 2024 | 46.29% |
| Dec 31, 2023 | 922.69% |
| Sep 30, 2023 | 49.99% |
| Jun 30, 2023 | 38.45% |
| Mar 31, 2023 | -3.69% |
| Dec 31, 2022 | -66.97% |
| Sep 30, 2022 | 34.69% |
| Jun 30, 2022 | 27.73% |
| Mar 31, 2022 | 27.72% |
| Dec 31, 2021 | -31.65% |
| Sep 30, 2021 | -19.43% |
| Jun 30, 2021 | -28.24% |